A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines.

@article{Omenn2014ANC,
  title={A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines.},
  author={Gilbert S. Omenn and Yuanfang Guan and Rajasree Menon},
  journal={Journal of proteomics},
  year={2014},
  volume={107},
  pages={103-12}
}
Combined RNA-Seq and proteomics analyses reveal striking differential expression of splice isoforms of key proteins in important cancer pathways and networks. Even between primary tumor cell lines from histologically similar inflammatory breast cancers, we find striking differences in hormone receptor-negative cell lines that are ERBB2 (Her2/neu)-amplified versus ERBB1 (EGFR) over-expressed with low ERBB2 activity. We have related these findings to protein-protein interaction networks… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
15 Extracted Citations
40 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 15 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 40 references

STAT3activation inHER2overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

  • ChungSS, GiehlN, WuY, JV Vadgama
  • Int J Oncol
  • 2014
2 Excerpts

Splicing in 4D. Science 2012;338:1547–8. cancer biomarker candidates: Differentially expressed splice tp://dx.doi.org/10.1016/j.jprot.2014.04.012

  • P Papasaikas, Valcarcel J. Evolution
  • 2014
2 Excerpts

Similar Papers

Loading similar papers…